A carregar...

Adjuvant endocrine therapy in patients with ductal carcinoma in situ: a population-based retrospective analysis from 2005-2012 in the National Cancer Database

BACKGROUND: Adjuvant endocrine therapy (AET) has been shown to reduce the risk of second breast cancer events in women with ductal carcinoma in situ (DCIS). There is no population-level evaluation of AET use in DCIS patients subsequent to standardized reporting of estrogen receptor (ER) status in ca...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg Oncol
Main Authors: Flanagan, Meghan R., Rendi, Mara H., Gadi, Vijayakrishna K., Calhoun, Kristine E., Gow, Kenneth W., Javid, Sara H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4552572/
https://ncbi.nlm.nih.gov/pubmed/26202556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-015-4668-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!